Trump’s Health Budget Reversal: Bipartisan Bill Counters 2025 Cuts

A recently enacted bipartisan budget represents a significant departure from proposed health funding cuts initially outlined by President Trump, reversing course on plans to dramatically reshape the Department of Health and Human Services (HHS). While the administration had proposed substantial reductions, particularly impacting biomedical research and public health infrastructure, the new law largely restores funding to levels consistent with prior budgets.

The shift is particularly notable given the administration’s earlier proposals to halve the budget for biomedical research and eliminate entire centers within the Centers for Disease Control and Prevention (CDC). The budget also sought to dismantle the mental health agency. However, the enacted budget increases funding for the National Institutes of Health (NIH) and fully funds centers that had been targeted for elimination. This outcome is being described as a “resounding rejection” of the administration’s initial vision for HHS.

Senator Tammy Baldwin, a Democrat from Wisconsin and ranking member of the appropriations subcommittee overseeing HHS, emphasized the intent behind the new budget’s detailed stipulations. According to Senator Baldwin, the goal was to “rein in an agency that has gone rogue with regard to personnel, with regard to how they choose to use appropriated funding.” The legislation includes specific instructions regarding the funding and staffing of key centers, requiring prompt disbursement of funds and prior congressional notification before any reorganization efforts are undertaken. This approach contrasts sharply with the previous continuing resolution, which provided less oversight.

The new law aims to limit the executive branch’s ability to act unilaterally, a concern raised following actions taken in 2025. However, questions remain regarding the administration’s willingness to comply with the new restrictions. Previous actions by Health and Human Services Secretary Robert F. Kennedy Jr. And his team were already seen as potentially violating existing congressional instructions regarding program funding and staffing.

Richard Frank, a senior fellow at the Brookings Institution and former HHS agency leader under President Obama, cautioned that the budget’s effectiveness hinges on congressional oversight. As Frank stated, the new guardrails will “only…work if their feet are held to the fire.” He highlighted Congress’s existing tools to hold the executive branch accountable and enforce the power of the purse, suggesting that a lack of assertive action thus far in the current presidential term has been a contributing factor to previous oversteps.

The practical implications of the new budget for health agencies remain uncertain. HHS has not yet publicly responded to inquiries regarding Secretary Kennedy’s reaction to the new funding allocations. Staff within health agencies express wariness, anticipating that the administration and Secretary Kennedy may seek alternative methods to modify or undermine programs they disfavor. Kennedy has a history of challenging established health policies, including litigation against HHS as an anti-vaccine activist and public criticism of agency personnel.

Given Kennedy’s demonstrated determination to leave his mark on HHS, and his past adversarial relationship with the agency, it is considered unlikely that he will fully embrace a restoration of the agency to its prior state. The coming year will be crucial in determining whether the new budget effectively alters the administration’s approach to managing HHS and implementing its health policies.

The budget’s passage comes after a period of significant uncertainty regarding the future of federal health programs. The initial proposals from the administration sparked concerns among public health advocates and researchers, who warned of the potential consequences of drastic funding cuts. The bipartisan agreement ultimately reached represents a compromise that prioritizes the continuation of existing programs and safeguards against unilateral actions by the executive branch. However, ongoing vigilance and assertive congressional oversight will be essential to ensure that the new budget’s intent is fully realized.

The situation highlights the ongoing tension between the executive and legislative branches regarding the allocation of federal resources and the implementation of health policy. While the new budget provides a temporary reprieve from the proposed cuts, the long-term trajectory of health funding will likely continue to be a subject of debate and negotiation in the years to come.